
Hain Celestial (HAIN) Receives a Buy from Maxim Group

Maxim Group analyst Anthony Vendetti has reiterated a Buy rating on Hain Celestial (HAIN) with a price target of $5.00, while the shares closed at $1.20. Vendetti, who covers the Healthcare sector, has an average return of -23.2% and a 25.86% success rate. Additionally, William Blair's Jon Andersen also issued a Buy rating for Hain Celestial, but TR | OpenAI maintained a Hold rating on the stock.
Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Hain Celestial yesterday and set a price target of $5.00. The company’s shares closed yesterday at $1.20.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Vendetti covers the Healthcare sector, focusing on stocks such as Dermata Therapeutics, Lucid Diagnostics, and Daxor. According to TipRanks, Vendetti has an average return of -23.2% and a 25.86% success rate on recommended stocks.
In addition to Maxim Group, Hain Celestial also received a Buy from William Blair’s Jon Andersen in a report issued yesterday. However, today, TR | OpenAI – 4o reiterated a Hold rating on Hain Celestial (NASDAQ: HAIN).

